{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:27:58Z","timestamp":1770996478091,"version":"3.50.1"},"reference-count":32,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Cervical cancer mortality has declined by 74% in the United States since the implementation of the Papanicolaou (Pap) test. Nevertheless, more than 12\u2009000 US women annually develop cervical cancer, and squamous cell carcinoma (SqCa) remains the predominant cervical malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate screening techniques used in the detection of SqCa of the cervix and provide insights regarding which technique(s) is (are) most efficacious in our study population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We retrospectively reviewed all available cytologic, human papillomavirus (HPV), and histologic malignancy burden data from patients diagnosed with SqCa. The clinical data were collected from 2 geographically and socioeconomically diverse hospital systems. Cases in which identified patients had a Pap test with a negative result\/unsatisfactory specimen within 5 years of SqCa tissue diagnosis were considered Pap test screening failures. Cases in which patients were diagnosed with HPV-negative SqCa were considered HPV screening failures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-eight cases (patients' ages ranging from 19 to 73 years) were identified. Of those, cytologic history was available for 64 cases present in our electronic medical history record. Three cases were cytology screening failures (one being an unsatisfactory specimen) and 3 cases were HPV screening failures (one being the cytologic unsatisfactory case). Although measuring sensitivity in practice has limitations, we calculated the SqCa detection sensitivity at 95.3% by Pap test alone and 97% when HPV DNA testing was incorporated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results highlight the necessity of combining Pap and HPV testing. Although the number of cases identified is relatively small, our data suggest detection failures will decrease as the practice of combining HPV and Pap testing increases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2014-0202-oa","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T09:48:28Z","timestamp":1433238508000},"page":"776-781","source":"Crossref","is-referenced-by-count":8,"title":["Squamous Cell Carcinoma of the Cervix: A Cytology-Histology-Human Papillomavirus Correlation in Clinical Practice"],"prefix":"10.5858","volume":"139","author":[{"given":"Ross A.","family":"Miller","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of South Dakota, Sioux Falls (Dr Miller); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Waters and Mody); and Sanford Health Pathology Clinic, Sanford USD Medical Center, Sioux Falls, South Dakota (Dr Tams). Dr Miller is now at the Department of Pathology and Genomic Medicine, Houston Methodist Hospit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay L.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina R.","family":"Mody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberlee C.","family":"Tams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"3","key":"2020081219285190900_i1543-2165-139-6-776-b01","doi-asserted-by":"crossref","first-page":"217","DOI":"10.18553\/jmcp.2010.16.3.217","article-title":"Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types","volume":"16","author":"Armstrong","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"2020081219285190900_i1543-2165-139-6-776-b02","unstructured":"US Cancer Statistics Working Group. United States Cancer Statistics: 1999\u20132009 Incidence and Mortality Web-Based Report. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2013. http:\/\/www.cdc.gov\/uscs. Accessed April 2, 2013."},{"issue":"10","key":"2020081219285190900_i1543-2165-139-6-776-b03","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.0.CO;2-D","article-title":"Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan","volume":"88","author":"Sung","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"2020081219285190900_i1543-2165-139-6-776-b04","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.24410","article-title":"Screening and adenocarcinoma of the cervix","volume":"125","author":"Sasieni","year":"2009","journal-title":"Int J Cancer"},{"issue":"4","key":"2020081219285190900_i1543-2165-139-6-776-b05","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","author":"The International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2007","journal-title":"Int J Cancer"},{"issue":"4","key":"2020081219285190900_i1543-2165-139-6-776-b06","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1012761717028","article-title":"Age-incidence relationships and time trends in cervical cancer in Sweden","volume":"17","author":"Hemminki","year":"2001","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"2020081219285190900_i1543-2165-139-6-776-b07","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinomas relative to squamous cell carcinoma of the uterine cervix in the United States, a 24-year population based-study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2020081219285190900_i1543-2165-139-6-776-b08","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2020081219285190900_i1543-2165-139-6-776-b09","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.20064","article-title":"Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1967\u20132000","volume":"100","author":"Wang","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"2020081219285190900_i1543-2165-139-6-776-b10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.1989.03420050087046","article-title":"The Papanicolaou test for cervical cancer detection: a triumph and a tragedy","volume":"261","author":"Koss","year":"1989","journal-title":"JAMA"},{"issue":"5","key":"2020081219285190900_i1543-2165-139-6-776-b11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gestafsson","year":"1997","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2020081219285190900_i1543-2165-139-6-776-b12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"2","key":"2020081219285190900_i1543-2165-139-6-776-b13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-1702(02)00187-9","article-title":"The viral etiology of cervical cancer","volume":"89","author":"Bosch","year":"2002","journal-title":"Virus Res"},{"issue":"3","key":"2020081219285190900_i1543-2165-139-6-776-b14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"2020081219285190900_i1543-2165-139-6-776-b15","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"2020081219285190900_i1543-2165-139-6-776-b16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"13","key":"2020081219285190900_i1543-2165-139-6-776-b17","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/cncr.28548","article-title":"Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009","volume":"120","author":"Rositch","year":"2014","journal-title":"Cancer"},{"key":"2020081219285190900_i1543-2165-139-6-776-b18","unstructured":"US Food and Drug Administration (FDA) Microbiology Devices Panel of the Medical Devices Advisory Committee: March 12, 2014 meeting. http:\/\/www.nlm.nih.gov\/medlineplus\/news\/fullstory_145075.html. Accessed May 20, 2014."},{"issue":"1","key":"2020081219285190900_i1543-2165-139-6-776-b19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-9378-7-26","article-title":"HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies","volume":"7","author":"Giorgi Rossi","year":"2012","journal-title":"Infect Agent Cancer"},{"issue":"4","key":"2020081219285190900_i1543-2165-139-6-776-b20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.27713","article-title":"Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe","volume":"132","author":"Tjalma","year":"2013","journal-title":"Int J Cancer"},{"issue":"11","key":"2020081219285190900_i1543-2165-139-6-776-b21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"2020081219285190900_i1543-2165-139-6-776-b22","article-title":"Cytopathology and more: evidence emerging for HPV-negative cervical cancer","author":"Zhao","year":"2014","journal-title":"CAP Today Online"},{"issue":"12","key":"2020081219285190900_i1543-2165-139-6-776-b23","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.5858\/arpa.2011-0609-OA","article-title":"Screening test results associated with cancer diagnosis in 287 women with cervical squamous cell carcinoma","volume":"136","author":"Li","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081219285190900_i1543-2165-139-6-776-b24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.2008.01990.x","article-title":"Anshu, Gregory M, Gupta SS, Singh N. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined","volume":"116","author":"Herbert","year":"2009","journal-title":"BJOG"},{"key":"2020081219285190900_i1543-2165-139-6-776-b25","article-title":"Cervicovaginal benchmarks 2011","author":"College of American Pathologists"},{"key":"2020081219285190900_i1543-2165-139-6-776-b26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jmv.2015","article-title":"Detection of high-risk HPV types by the hybrid capture 2 test","volume":"65","author":"Terry","year":"2001","journal-title":"J Med Virol"},{"issue":"4","key":"2020081219285190900_i1543-2165-139-6-776-b27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cncr.10717","article-title":"Measuring sensitivity in gynecologic cytology: a review","volume":"96","author":"Renshaw","year":"2002","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"2020081219285190900_i1543-2165-139-6-776-b28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/dc.10132","article-title":"D\u00e9j\u00e0 vu in Pap testing: return of the 5% false-negative fraction and the zero-error rate [editorial]","volume":"26","author":"Renshaw","journal-title":"Diagn Cytopathol"},{"issue":"11","key":"2020081219285190900_i1543-2165-139-6-776-b29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer Randomized Controlled Trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2020081219285190900_i1543-2165-139-6-776-b30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"and the NTCC Working Group. Human papillomavirus testing and liquidbased cytology in primary screening among younger women: results at recruitment from the NTCC randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"key":"2020081219285190900_i1543-2165-139-6-776-b31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1309\/AJCP6J2OEFOYTRFD","article-title":"HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening","volume":"138","author":"Rossi","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"2020081219285190900_i1543-2165-139-6-776-b32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictos 2 Study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/6\/776\/1614801\/arpa_2014-0202-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/6\/776\/1614801\/arpa_2014-0202-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:34:17Z","timestamp":1764790457000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/139\/6\/article-p776.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2014-0202-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,1]]}}}